1- Amlodipine & Atenolol Tablets
Description:
Amlodipine & Atenolol Tablets are a combination medication used to treat and prevent hypertension (high blood pressure)—a chronic condition where blood pressure against artery walls becomes too high. If left unmanaged, hypertension can lead to heart disease, stroke, kidney damage, and blood vessel complications.
Therapeutic Class: Antihypertensive
Drug Type: Calcium Channel Blocker + Beta Blocker Combination
Composition:
-
Amlodipine: A calcium channel blocker that relaxes and widens blood vessels, improving blood flow.
-
Atenolol: A beta-blocker that slows the heart rate and reduces the heart’s workload by blocking stress hormones like adrenaline.
Indications:
-
Hypertension (high blood pressure)
-
Angina (chest pain)
-
Cardiovascular protection
Available Strengths:
-
Amlodipine 5 mg + Atenolol 25 mg
-
Amlodipine 5 mg + Atenolol 50 mg
-
Amlodipine 10 mg + Atenolol 50 mg
Packaging: Blister / Bottle Pack
Shelf Life: 24–36 months
Compliance: WHO-GMP, ISO Certified
2- Amlodipine & Losartan Potassium Tablets
Description:
Amlodipine & Losartan Potassium Tablets are a dual-action antihypertensive formulation used to treat high blood pressure and reduce the risk of related complications such as heart attack, stroke, and kidney damage.
Therapeutic Class: Antihypertensive
Drug Type: Calcium Channel Blocker + Angiotensin II Receptor Blocker (ARB) Combination
Composition:
-
Amlodipine: A calcium channel blocker that relaxes blood vessels for smoother blood flow.
-
Losartan Potassium: An ARB that prevents the narrowing of blood vessels by blocking the action of angiotensin II.
Indications:
-
Hypertension
-
Cardiovascular risk reduction
-
Chronic kidney disease associated with high blood pressure
Available Strengths:
-
Amlodipine 5 mg + Losartan 50 mg
-
Amlodipine 5 mg + Losartan 100 mg
-
Amlodipine 10 mg + Losartan 50 mg
-
Amlodipine 10 mg + Losartan 100 mg
Packaging: Blister / Bottle Pack
Shelf Life: 24–36 months
Compliance: WHO-GMP, ISO Certified
3- Benidipine Hydrochloride Tablets
Description:
Benidipine Hydrochloride Tablets are used to treat hypertension (high blood pressure) and angina pectoris (chest pain). It is a long-acting calcium channel blocker that helps lower blood pressure by relaxing and widening blood vessels, improving blood flow and reducing the heart's workload.
Therapeutic Class: Antihypertensive
Drug Type: Dihydropyridine Calcium Channel Blocker (CCB)
Indications:
-
Hypertension (High Blood Pressure)
-
Angina Pectoris (Chest Pain)
-
Vascular protection in chronic cardiovascular conditions
Mechanism of Action:
Benidipine blocks calcium channels in blood vessels, leading to vasodilation and reduced vascular resistance. Unlike other calcium channel blockers, it acts on L-, T-, and N-type calcium channels, making it effective and well-tolerated for long-term therapy.
Available Strengths:
-
Benidipine Hydrochloride 4 mg
-
Benidipine Hydrochloride 8 mg
Dosage Form: Oral Tablets
Packaging: Blister Pack / Bottle Pack (customized per export requirement)
Shelf Life: 24–36 months
Manufacturing Compliance: WHO-GMP / ISO Certified Facilities
4- Bisoprolol Fumarate Tablets
Description:
Bisoprolol Fumarate Tablets are prescribed for the treatment of hypertension (high blood pressure), angina (chest pain), and chronic heart failure. This medicine belongs to a class of drugs called beta-1 selective beta-blockers, which help reduce the heart rate and the heart’s workload, leading to improved cardiac function and controlled blood pressure.
Therapeutic Class: Antihypertensive / Cardiovascular Agent
Drug Type: Beta-1 Selective Beta-Blocker
Indications:
-
Hypertension (High Blood Pressure)
-
Stable Angina
-
Chronic Heart Failure
-
Post-myocardial infarction (as directed)
Mechanism of Action:
Bisoprolol selectively blocks beta-1 adrenergic receptors in the heart, reducing cardiac output and lowering blood pressure. It also helps prevent future cardiac events by decreasing the strain on the heart.
Available Strengths:
-
Bisoprolol Fumarate 2.5 mg
-
Bisoprolol Fumarate 5 mg
-
Bisoprolol Fumarate 10 mg
Dosage Form: Oral Tablets
Packaging: Blister / Bottle Pack (customized for domestic and international requirements)
Shelf Life: 24–36 months
Manufacturing Standards:
-
WHO-GMP Certified
-
ISO 9001:2015 Compliant
-
Available with full regulatory support (COA, MSDS, Product Dossier)
5- Chlorthalidone Tablets
Description:
Chlorthalidone Tablets are used in the treatment of hypertension (high blood pressure) and edema (fluid retention) associated with conditions like heart failure, kidney disorders, and liver disease. Chlorthalidone is a thiazide-like diuretic that helps the body eliminate excess salt and water, thereby reducing blood pressure and swelling.
Therapeutic Class: Antihypertensive / Diuretic
Drug Type: Thiazide-like Diuretic
Indications:
-
Primary Hypertension
-
Edema associated with Congestive Heart Failure, Renal Disorders, or Cirrhosis
-
Adjunct treatment in fluid retention disorders
-
Cardiovascular risk reduction in hypertensive patients
Mechanism of Action:
Chlorthalidone works by increasing the excretion of sodium and water through the kidneys. This reduces blood volume and peripheral resistance, which in turn helps lower blood pressure.
Available Strengths:
-
Chlorthalidone 12.5 mg
-
Chlorthalidone 25 mg
-
Chlorthalidone 50 mg
Dosage Form: Oral Tablets
Packaging: Blister Pack / Bottle Pack (customized for export or hospital use)
Shelf Life: 24–36 months
Compliance & Certifications:
-
WHO-GMP Certified
-
ISO 9001:2015
-
Regulatory Documents: COA, MSDS, Stability Data, Product Dossier (on request)
6- Clopidogrel Tablets
Description:
Clopidogrel Tablets are an antiplatelet medication used to prevent blood clots in patients at risk of heart attack, stroke, and other cardiovascular events. By inhibiting platelet aggregation, Clopidogrel helps maintain smooth blood flow in arteries, reducing the chance of clot formation.
Therapeutic Class: Antiplatelet Agent
Drug Type: P2Y12 Platelet Inhibitor
Indications:
-
Prevention of atherothrombotic events in patients with recent myocardial infarction (heart attack), stroke, or peripheral arterial disease
-
Used in combination with aspirin in acute coronary syndrome (ACS)
-
Post percutaneous coronary intervention (PCI) with stent placement to prevent stent thrombosis
Mechanism of Action:
Clopidogrel selectively and irreversibly inhibits the P2Y12 ADP receptor on platelet surfaces, preventing platelet activation and aggregation, thereby reducing the risk of thrombus formation.
Available Strengths:
-
Clopidogrel 75 mg
-
Clopidogrel 300 mg (loading dose)
Dosage Form: Oral Tablets
Packaging: Blister Pack / Bottle Pack (export standard packaging available)
Shelf Life: 24–36 months
Certifications:
-
WHO-GMP Certified
-
ISO 9001:2015 Compliant
-
Full regulatory dossier and documentation available on request
7- Clopidogrel & Aspirin Tablets
Description:
Clopidogrel & Aspirin Tablets combine two powerful antiplatelet agents used to prevent blood clots in patients at risk of heart attack, stroke, and other cardiovascular complications. This dual therapy effectively reduces platelet aggregation and provides enhanced protection against thrombotic events.
Therapeutic Class: Antiplatelet Combination Therapy
Drug Type: P2Y12 Platelet Inhibitor + NSAID (Aspirin)
Indications:
-
Prevention of atherothrombotic events in patients with acute coronary syndrome (ACS)
-
Secondary prevention following myocardial infarction (heart attack) or ischemic stroke
-
Prevention of stent thrombosis after percutaneous coronary intervention (PCI)
-
Reduction of cardiovascular risk in high-risk patients
Mechanism of Action:
-
Clopidogrel: Irreversibly inhibits the P2Y12 ADP receptor on platelets, preventing platelet activation and aggregation.
-
Aspirin: Irreversibly inhibits cyclooxygenase-1 (COX-1), reducing thromboxane A2 production, which decreases platelet aggregation.
Available Strengths:
-
Clopidogrel 75 mg + Aspirin 75 mg
-
Clopidogrel 75 mg + Aspirin 100 mg
Dosage Form: Oral Tablets
Packaging: Blister / Bottle Pack (custom packaging available for export)
Shelf Life: 24–36 months
Quality Certifications:
-
WHO-GMP Certified
-
ISO 9001:2015 Certified
-
Complete regulatory dossier and documentation available
8- Atorvastatin 10 mg & Clopidogrel 75 mg Tablets
Description:
Atorvastatin & Clopidogrel Tablets combine a cholesterol-lowering agent with an antiplatelet medication to help manage cardiovascular risks effectively. This combination is designed to lower LDL cholesterol and prevent blood clot formation, reducing the risk of heart attacks, strokes, and other cardiovascular events in high-risk patients.
Therapeutic Class:
-
Lipid-lowering Agent (Statin)
-
Antiplatelet Agent
Drug Types:
-
Atorvastatin: HMG-CoA reductase inhibitor
-
Clopidogrel: P2Y12 ADP receptor inhibitor
Indications:
-
Prevention of cardiovascular events in patients with atherosclerosis or coronary artery disease
-
Secondary prevention post myocardial infarction (heart attack) or ischemic stroke
-
Patients with high cholesterol and elevated risk of thrombotic events
Mechanism of Action:
-
Atorvastatin: Inhibits HMG-CoA reductase enzyme, reducing cholesterol synthesis in the liver and lowering LDL cholesterol levels.
-
Clopidogrel: Irreversibly inhibits the P2Y12 ADP receptor on platelets, preventing platelet aggregation and clot formation.
Available Strengths:
-
Atorvastatin 10 mg + Clopidogrel 75 mg
Dosage Form: Oral Tablets
Packaging: Blister Pack / Bottle Pack (customizable for export needs)
Shelf Life: 24–36 months
Certifications:
-
WHO-GMP Certified
-
ISO 9001:2015 Compliant
-
Regulatory dossiers and documentation available on request
9- Dapagliflozin & Metformin Tablets
Description:
Dapagliflozin & Metformin Tablets combine two effective antidiabetic agents used to improve blood sugar control in patients with type 2 diabetes mellitus. This combination helps reduce blood glucose levels by increasing urinary glucose excretion and decreasing hepatic glucose production, supporting better glycemic management.
Therapeutic Class: Antidiabetic Combination
Drug Types:
-
Dapagliflozin: SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor
-
Metformin: Biguanide
Indications:
-
Management of type 2 diabetes mellitus, especially in patients inadequately controlled with metformin alone
-
Adjunct to diet and exercise for improved glycemic control
-
May support weight reduction and cardiovascular benefits as part of diabetes management
Mechanism of Action:
-
Dapagliflozin: Blocks SGLT2 in the kidneys, reducing glucose reabsorption and increasing glucose excretion through urine.
-
Metformin: Decreases hepatic glucose production and improves insulin sensitivity.
Available Strengths:
-
Dapagliflozin 5 mg + Metformin 500 mg
-
Dapagliflozin 10 mg + Metformin 1000 mg
-
Extended-release (ER) formulations available on request
Dosage Form: Oral Tablets
Packaging: Blister Pack / Bottle Pack (customizable for export and domestic use)
Shelf Life: 24–36 months
Certifications:
-
WHO-GMP Certified
-
ISO 9001:2015 Compliant
-
Full regulatory documentation available (COA, MSDS, Product Dossier)
9- Enalapril Maleate Tablets
Description:
Enalapril Maleate Tablets are an effective antihypertensive medication used to treat high blood pressure (hypertension) and heart failure. As an ACE (Angiotensin-Converting Enzyme) inhibitor, Enalapril helps relax blood vessels, making it easier for the heart to pump blood and reducing strain on the cardiovascular system.
Therapeutic Class: ACE Inhibitor
Drug Type: Antihypertensive Agent
Indications:
-
Treatment of hypertension to lower high blood pressure
-
Management of heart failure and prevention of associated complications
-
Improvement of survival after heart attacks
-
Prevention of kidney damage in patients with diabetes-related kidney disease
Mechanism of Action:
Enalapril inhibits the ACE enzyme, reducing the production of angiotensin II, a substance that narrows blood vessels. This results in vasodilation, decreased blood pressure, and reduced workload on the heart.
Available Strengths:
-
Enalapril Maleate 5 mg
-
Enalapril Maleate 10 mg
-
Enalapril Maleate 20 mg
Dosage Form: Oral Tablets
Packaging: Blister Pack / Bottle Pack (customizable for export and domestic markets)
Shelf Life: 24–36 months
Certifications:
-
WHO-GMP Certified
-
ISO 9001:2015 Compliant
-
Regulatory and quality documentation available on request